Antioxidants, but not B-group vitamins increase the resistance of low- density lipoprotein to oxidation: A randomized, factorial design, placebo- controlled trial

Atherosclerosis

Volumn 144, Issue 2, 1999, Pages 419-427

  Woodside, Jayne V ^a   Young, Ian S ^a   Yarnell, John W G ^a   Roxborough, Heather E ^a   McMaster, Dorothy ^a   McCrum, Evelyn E ^a   Gey, K Fred ^b   Evans, Alun ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Antioxidant vitamins; B group vitamins; Cardiovascular disease; LDL oxidation

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CHOLESTEROL; COBALAMIN; FOLIC ACID ANTAGONIST; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN; PYRIDOXAL 5 PHOSPHATE; TRIACYLGLYCEROL; VITAMIN B GROUP;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG POTENTIATION; HUMAN; HUMAN EXPERIMENT; LIPID PEROXIDATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ADULT; ANTIOXIDANTS; CORONARY ARTERIOSCLEROSIS; DOUBLE-BLIND METHOD; HOMOCYSTEINE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATION-REDUCTION; RISK FACTORS; VITAMIN B COMPLEX;

EID: 0032976787     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00334-7     Document Type: Article

References (64)

1. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. New Engl. J. Med. 320:1989;915-924.
2. Gey K.F. Ten year retrospective study on the antioxidant hypothesis of arteriosclerosis: threshold plasma levels of antioxidant micronutrients related to minimum cardiovascular risk. J. Nutr. Biochem. 6:1995;206-236.
3. Jialal I., Devaraj S. Low-density lipoprotein oxidation, antioxidants and atherosclerosis: a clinical biochemistry perspective. Clin. Chem. 42:1996;498-506.
4. Ziouzenkova O., Gieseg S.P., Ramos P., Esterbauer H. Factors affecting resistance of low density lipoproteins to oxidation. Lipids. 31:1996;S71-S76.
5. Ziouzenkova O., Sevanian A., Abuja P.M., Ramos P., Esterbauer H. Copper can promote oxidation of LDL by markedly different mechanisms. Free Radic. Biol. Med. 24:1998;607-623.
6. Bowry V.W., Stocker R. Tocopherol-mediated peroxidation - the prooxidant effect of vitamin-E on the radical-initiated oxidation of human low-density-lipoprotein. J. Am. Chem. Soc. 115:1993;6029-6044.
7. Virella G., Virella I., Leman R.B., Pryor M.B., Lopess-Virella M.F. Anti-oxidized low-density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers. Int. J. Clin. Lab. Res. 23:1993;95-101.
8. Salonen J.T., Yla-Herttuala S., Yamamoto R., Butler S., Korpela H., Salonen R., Nyyssonen K., Palinski W., Witztum J.L. Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet. 339:1992;883-887.
9. Bellomo G., Maggi E., Poli M., Agosta F.G., Bollati P., Finardi G. Autoantibodies against oxidatively modified low-density lipoproteins in NIDDM. Diabetes. 44:1995;60-66.
10. Gey K.G., Puska P., Jordan P., Moser U.K. Inverse correlation between vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am. J. Clin. Nutr. 53:1991;S326-S334.
11. Stampfer M.J., Hennekens C.H., Manson J.A.-E., Colditz G.A., Rosner B., Willett W.C. Vitamin E consumption and the risk of coronary heart disease in women. New Engl. J. Med. 328:1993;1444-1449.
12. Rimm E.B., Stampfer M.J., Aschherio A., Giovannucci E., Colditz G.A., Willett W.C. Vitamin E consumption and the risk of coronary heart disease in men. New Engl. J. Med. 328:1993;1450-1456.
13. Gaziano J.M., Manson J.E., Hennekens C.H. Natural antioxidants and cardiovascular disease: observational epidemiologic studies and randomized trials. Frei B. Natural Antioxidants in Human Health. 1994;387-409 Academic Press, San Diego.
14. Singh R.B., Niaz A.M., Ghosh S., Agarwal P., Ahmad S., Begum R., Onouchi Z., Kummerow F.A. Randomized, controlled trial of antioxidant vitamins and cardioprotective diet on hyperlipidemia, oxidative stress and development of experimental atherosclerosis: the Diet and Antioxidant Trial on Atherosclerosis (DATA). Cardiovasc. Drugs Ther. 9:1995;763-771.
15. Jessup W., Rankin S.M., De Whalley C.V., Hoult J.R., Scott J., Leake D.S. Alpha-tocopherol consumption during low-density lipoprotein oxidation. Biochem. J. 265:1990;399-405.
16. Wiklund O., Mattson L., Bjoernheden T., Camejo G., Bondjiers G. Uptake and degradation of low-density lipoproteins in atherosclerotic rabbit aorta: role of local LDL modification. J. Lipid Res. 32:1991;55-62.
17. Jialal I., Norkus E.P., Cristol L., Grundy S.M. Beta-carotene inhibits the oxidative modification of low-density lipoprotein. Biochem. Biophys. Acta. 1086:1991;134.
18. Fuller C.J., Grundy S.M., Norkus E.P., Jialal I. Effect of ascorbate supplementation on low-density lipoprotein oxidation in smokers. Atherosclerosis. 119:1996;139-150.
19. Kagan V.E., Serbinova E.A., Forte T., Scita G., Packer L. Recycling of vitamin E in human low density lipoproteins. J. Lipid Res. 33:1992;385-397.
20. Ziouzenkova O, Gieseg SP, Ramos P, Esterbauer H. @Factors affecting the resistance of low-density lipoproteins to oxidation. Lipids 1996;31:S71-S76.
21. Diaz M.N., Frei B., Vita J.A., Keaney J.F. Antioxidants and atherosclerotic heart disease. New Engl. J. Med. 337:1997;408-416.
22. The effect of vitamin E and β carotene on the incidence of lung cancer and other cancers in male smokers. New Engl. J. Med. 330:1994;1029-1035.
23. Omenn G.S., Goodman G.E., Thornquist M.D., Balmes J., Cullen M.R., Glass A., Keogh J.P., Meyskens F.L., Valanis B., Williams J.H., Barnhart S., Hammar S. Effects of a combination of β carotene and vitamin A on lung cancer and cardiovascular disease. New Engl. J. Med. 334:1996;1150-1155.
24. Hennekens C.H., Buring J.E., Manson J.E., Stampfer M., Rosner B., Cook N.R., Belanger C., LaMotte F., Gaziano J.M., Ridker P.M., Willett W., Peto R. Lack of effect of long-term supplementation with β carotene on the incidence of malignant neoplasms and cardiovascular diasease. New Engl. J. Med. 334:1996;1145-1149.
25. Stephens N.G., Parsons A., Schofield P.M., Kelly F., Cheeseman K., Mitchinson M.J., Brown M.J. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 347:1996;781-786.
26. Boushey C.J., Beresford S.A.A., Omenn G.S., Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. J. Am. Med. Assoc. 274:1995;1049-1057.
27. 6, and folate nutritional status in men with hyperhomocysteinemia. Am. J. Clin. Nutr. 57:1993;47-53.
28. Woodside J.V., Yarnell J.W.G., McMaster D., Young I.S., McCrum E.E., Patterson C.C., Gey K.F., Evans A.K. The effect of B-group and antioxidant vitamins on hyperhomocysteinemia: a double blind, randomised factorial-design controlled trial. Am. J. Clin. Nutr. 67:1998;858-866.
29. Starkebaum G., Harlan J.M. Endothelial cell injury due to copper-catalysed hydrogen peroxide generation from homocysteine. J. Clin. Invest. 77:1986;1370-1376.
30. Heinecke J.W., Rosen H., Suzuki L.A., Chait A. The role of sulphur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. J. Biol. Chem. 262:1987;10098-10103.
31. Parthasarathy S. Oxidation of low density lipoprotein by thiol compounds leads to its recognition by the acetyl LDL receptor. Biochem. Biophys. Acta. 917:1987;337-340.
32. Vuillemier J.P., Keck E. Fluorometric assay of vitamin C in biological materials using a centrifugal analyser with fluorescence attachment. J. Micronut. Analysis. 5:1989;25-34.
33. Ubbink J.B., Vermaak W.J.H., Bissbort S. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J. Chromatogr. 565:1991;441-446.
34. McDowell I.F.W., McEneny J., Trimble E.R. A rapid method for measurement of the susceptibility to oxidation of low-density lipoprotein. Ann. Clin. Biochem. 32:1995;167-174.
35. Craig W.Y., Poulin S.E., Nelson C.P., Ritchie R.F. ELISA of IgG antibody to oxidized low-density-lipoprotein-effects of blocking buffer and method of data expression. Clin. Chem. 40:1994;882-888.
36. 6 in human serum. J. Liquid Chromatogr. 15:1992;897-914.
37. Catignani G.L., Bieri J.G., Driskell W.J. Simultaneous determination of retinol and α-tocopherol in serum or plasma by liquid chromatography. Clin. Chem. 29:1983;708-712.
38. Thurnham D.I., Smith E., Flora P.S. Concurrent liquid-chromatographic assay of retinol, α-tocopherol, β-carotene, α-carotene, lycopene, and β-cryptoxanthin in plasma, with tocopherol acetate as internal standard. Clin. Chem. 34:1988;377-381.
39. Armitage P., Berry G. Statistical Methods in Medical Research. 3rd ed. 1994;Blackwell Scientific Productions, Oxford.
40. Jordan P., Brubacher D., Moser U., Stahelin H.B., Gey K.F. Vitamin E and vitamin A concentrations in plasma adjusted for cholesterol and triglycerides by multiple regression. Clin. Chem. 41:1995;924-927.
41. Halvorsen B., Brude I., Drevon C.A., Nysom J., Ose L., Christiansen E.N., Nenseter M.S. Effect of homocysteine on copper ion-catalysed, azo compound-initiated, and mononuclear cell-mediated oxidative modification of low density lipoprotein. J. Lipid Res. 37:1996;1591-1600.
42. Jialal I., Grundy S.M. Effect of combined supplementation with α-tocopherol, ascorbate and β carotene on low-density lipoprotein oxidation. Circulation. 88:1993;2780-2786.
43. Abbey M., Nestel P.J., Baghurst P.A. Antioxidant vitamins and low-density-lipoprotein oxidation. Am. J. Clin. Nutr. 58:1993;525-532.
44. Halevy D., Thiery J., Nagel D., Arnold S., Erdmann E., Hofling B., Cremer P., Seidel D. Increased oxidation of LDL in patients with coronary heart disease is independent from dietary vitamins E & C. Arterioscler. Thromb. Vasc. Biol. 17:1997;1432-1437.
45. Tardif J.C., Cote G., Lesperance J., Bourassa M., Lambert J., Doucet S., Bilodeau L., Nattel S., de Guise P. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. New Engl. J. Med. 337:1997;365-372.
46. Kita T., Nagano Y., Yokode M., Ishii K., Kume N., Ooshima A., Yoshida H., Kawai C. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc. Natl. Acad. Sci. USA. 84:1987;5928-5931.
47. Shaish A., Daugherty A., O'Sullivan F., Schonfeld G., Heinecke J.W. Beta-carotene inhibits atherosclerosis in hypercholesterolemic rabbits. J. Clin. Invest. 96:1995;2075-2082.
48. Kleinfeld H.A., Hak-Lemmers H.L., Hectors M.P., de Fouw N.J., Demacker P.N., Stalenhoef A.F. Vitamin E and fatty acid intervention does not attenuate the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Arterioscler. Thromb. Vasc. Biol. 15:1995;290-297.
49. Keaney J.F., Gaziano J.M., Xu A., Frei B., Currance-Lentano K., Shwaery G.T., Loscalzo J., Vita J.A. Low dose α-tocopherol improves and high dose α-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. J. Clin. Invest. 93:1994;844-851.
50. Keaney J.F., Xu A., Cunningham D., Jackson T., Frei B., Vita J.A. Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation. J. Clin. Invest. 95:1995;2520-2529.
51. Regnstrom J., Nilsson J., Tornvall P., Landou C., Hamsten A. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet. 339:1992;1183-1186.
52. Armstrong V.W., Wieland E., Diedrich F., Renner A., Rath W., Kreuzer H., Kuhn W., Oellerich M. Serum antibodies to oxidised low-density lipoprotein in pre-eclamptic and coronary disease. Lancet. 343:1994;1570-1571.
53. Maggi E., Finrdi G., Poli M., Bollati P., Filipponi M., Stefano P.L., Paolini G., Grossi A., Clot P., Albano E., Bellomo G. Specificity of autoantibodies against oxidized LFL as an additional marker for atherosclerotic risk. Coron. Artery Dis. 4:1993;1119-1122.
54. Parums D.V., Brown D.L., Mitchinson M.J. Serum antibodies to oxidized low-density lipoprotein and ceroid in chronic periaortitis. Arch. Pathol. Lab. Med. 114:1990;383-387.
55. Schumacher M., Eber B., Tatzber F., Kaufmann P., Esterbauer H., Klein W. LDL oxidation and coronary atherosclerosis. Lancet. 340:1992;123.
56. Eber B., Schumacher M., Tatzer F., KauLmann P., Luha O., Esterbauer H., Klein W. Autoantibodies to oxidized low density lipoproteins in restenosis following coronary angioplasty. Cardiology. 84:1994;310-315.
57. Bouiller A., Hamon M., Walters-Laporte E., Martin-Nizart F., Mackereel R., Fruchart J., Bertrand M., Duriez P. Detection of autoantibodies against oxidized low-density lipoproteins and of IgG-bound low density lipoproteins in patients with coronary artery disease. Clin. Chim. Acta. 238:1995;1-10.
58. Hoogerbrugge N., Zillikens M.C., Jansen H., Meeter K., Deckers J.W., Birkenhager J.C. Estrogen replacement decreases the level of antibodies against oxidised low-density lipoprotein in postmenopausal women with coronary heart disease. Metabolism. 47:1998;675-680.
59. 2-isoprostanes) in plasma and LDL exposed to oxidative stress in vitro. J. Clin. Invest. 93:1994;998-1004.
60. 2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. New Engl. J. Med. 332:1995;1198-1203.
61. Reilly M., Delanty N., Lawson J.A., FitzGerald G.A. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation. 94:1996;19-25.
62. Hennekens C.H. Antioxidant vitamins and cardiovascular disease: current perspectives and future directions. Eur. Heart J. 18:1997;177-179.
63. Buring JE, Hennekens CH, for the Women's Health Study Research Group. The Women's Health Study: Summary of the study design. J Myocard Ischemia 1992;4:27-29.
64. Manson JE, Gaziano JM, Spelsberg A, et al. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women: rationale, design and methods. Ann Epidemiol 1995;5:261-268.